Synergistic effect of the rotary motor and intramolecular charge transfer in novel aza-BODIPY for phototherapeutic glioblastoma via damaging mitochondria
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photoreceptor and optogenetics research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (69)
Show source-provided references
1. Comprehensive portrait of recurrent glioblastoma multiforme inmolecular and clinical characteristics10.18632/oncotarget.5038 ↗
2. WHO 2016 classification of gliomas, neuropathol10.1111/nan.12432 ↗
3. Effect of fractal-shaped outer boundary of glioblastoma multiforme on drug delivery10.1016/j.cmpb.2019.06.031 ↗
4. Advances in experimental targeted therapy and immunotherapy for patients with glioblastoma multiforme10.21873/anticanres.11285 ↗
5. The 2021 WHO classification of tumors of the central nervous system: a summary10.1093/neuonc/noab106 ↗
6. Recent update in pharmacological agents for optic pathway glioma10.14791/btrt.2022.0006 ↗
7. Recent updates on radiation therapy for pediatric optic pathway glioma10.14791/btrt.2022.0003 ↗
8. Surgical neuro-oncology: management of glioma10.1016/j.ncl.2021.11.003 ↗
9. The survival benefits of surgical resection and adjuvant therapy for patients with brainstem glioma
10. A dual-targeted organic photothermal agent for enhanced photothermal therapy10.1002/anie.201811273 ↗
11. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
12. Advances in photothermal nanomaterials for biomedical, environmental and energy applications10.1039/D1NR04197E ↗
13. Near-infrared-II activated inorganic photothermal nanomedicines10.1016/j.biomaterials.2020.120459 ↗
14. Supramolecular photothermal effects: a promising mechanism for efficient thermal conversion10.1002/anie.201909825 ↗
15. A heat shock protein-inhibiting molecular photothermal agent for mild-temperature photothermal therapy10.1039/D2CC05525B ↗
16. In-situ synthesis of melanin in tumor with engineered probiotics for hyperbaric oxygen-synergized photothermal immunotherapy10.1016/j.nantod.2022.101632 ↗
17. Conjugated-polymer-based nanomaterials for photothermal therapy10.1021/acsapm.0c00680 ↗
18. Acid-triggered two-stage superlarge redshift absorption for turn-on type photothermal conversion at the first and second near-infrared window10.1039/D2TA08985H ↗
19. An upconversion nanoplatform based multi-effective theatment for Parkinson's disease10.1016/j.cej.2023.142959 ↗
20. Unique double intramolecular and intermolecular exciton coupling in ethene-bridged aza-BODIPY dimers for high-efficiency near-infrared photothermal conversion and therapy10.1002/anie.202211081 ↗
21. Stereochemical control of secondary benzamide-based BODIPY emitters10.1002/chem.202300383 ↗
22. A facile way to obtain near-infrared room-temperature phosphorescent soft materials based on Bodipy dyes10.1039/C9SC05502A ↗
23. Versatile phototheranostic system: aza-BODIPY-based nanoparticles with B,O-chelated core and diiodine10.1016/j.dyepig.2023.111786 ↗
24. Dual-color photoconvertible BODIPY dyes based on visible-light photouncaging of nitrobenzyl moieties for living-cell imaging
25. Single-molecule localization microscopy and tracking with red-shifted states of conventional BODIPY conjugates in living cells10.1038/s41467-019-11384-6 ↗
26. Evolution of Aza-BODIPY dyes-A hot topic10.1016/j.ccr.2023.215428 ↗
27. An electronic-tuning strategy to improve the responsiveness of nitric oxide probe10.1016/j.dyepig.2023.111486 ↗
28. BODIPY-based probes for hypoxic environments10.1016/j.ccr.2023.215041 ↗
29. Supramolecular photosensitizer enables oxygen-independent generation of hydroxyl radicals for photodynamic therapy10.1021/jacs.2c11868 ↗
30. Structural optimization of BODIPY photosensitizers for enhanced photodynamic antibacterial activities10.1039/D3BM00073G ↗
31. Microlasers from AIE‐active BODIPY derivative
32. A molecular recognition platform for the simultaneous sensing of diverse chemical weapons10.1039/D2SC00299J ↗
33. Conformationally restricted and ring-fused aza-BODIPYs as promising near infrared absorbing and emitting dyes10.1016/j.ccr.2022.214709 ↗
34. Aryl-boron-substituted BODIPYs: direct access via aluminum-chloride-mediated arylation from arylstannanes and tuning the optoelectronic properties10.1021/acs.orglett.2c04184 ↗
35. On-demand drug release nanoplatform based on fluorinated aza-BODIPY for imaging-guided chemo-phototherapy10.1016/j.biomaterials.2020.120211 ↗
36. Cardiolipin-targeted NIR-II fluorophore causes “avalanche effects” for Re-engaging cancer apoptosis and inhibiting metastasis10.1021/jacs.2c08602 ↗
37. Conformationally restrained coumarin hemicyanines: improved quantum yields and potential applications in bioimaging and photodynamic therapy10.1016/j.snb.2023.133832 ↗
38. Acceptor-donor-acceptor structured deep-red AIE photosensitizer: lysosome-specific targeting, in vivo long-term imaging, and effective photodynamic therapy10.1016/j.cej.2021.132638 ↗
39. Activatable near-infrared fluorescent and photoacoustic dual-modal probe for highly sensitive imaging of sulfatase in vivo10.1021/acssensors.3c00201 ↗
40. Near-infrared bodipy-based molecular rotors for β-amyloid imaging in vivo10.1002/adhm.202300733 ↗
41. Activatable BODIPY-chromene NIR-II probes with small spectral crosstalk enable high-contrast in vivo bioimaging10.1039/D3CC01742G ↗
42. Synthesis and properties of BF2-3,3’-dimethyldiarylazadipyrromethene near-infrared fluorophores10.1021/ol401434c ↗
43. Effect of the aza-N-bridge and push-pull moieties: a comparative study between BODIPYs and aza-BODIPYs10.1021/acs.joc.1c02525 ↗
44. Non-aryl substituted aza-BODIPYs at 1,7- or 3,5-sites: synthesis, structures, optical properties, and applications10.1039/D2TC05048J ↗
45. Attachment of -tBu groups to aza-BODIPY core at 3,5-sites with ultra-large Stokes shift to enhance photothermal therapy through apoptosis mechanism
46. Synthesis of aza-BODIPYs with barrier-free rotation of the –tBu group at 3-site and enhancement of photothermal therapy by triggering cancer cell apoptosis10.1039/D2TB01513G ↗
47. Aza-BODIPY with two efficacious fragments for NIR light-driven photothermal therapy by triggering cancer cell apoptosis10.1039/D3TB02132G ↗
48. 1,7-Di-tert-butyl-Substituted aza-BODIPYs by low-barrier rotation to enhance a photothermal-photodynamic effect
49. Aniline as a TICT rotor to derive methine fluorogens for biomolecules: a curcuminoid-BF2 compound for lighting up HSA/BSA
50. Engineering of BODIPY-based theranostics for cancer therapy10.1016/j.ccr.2022.214908 ↗
51. BODIPY 493 acts as a bright buffering fluorogenic probe for super-resolution imaging of lipid droplet dynamics10.1016/j.cclet.2022.03.120 ↗
52. Does twisted π-conjugation framework always induce efficient intersystem crossing? A case study with benzo[b]- and [a]Phenanthrene-Fused bodipy derivatives and identification of a dark state10.1021/acs.jpcb.1c03189 ↗
53. Origin of intersystem crossing in highly distorted organic molecules: a case study with red light-absorbing N,N,O,O-boron-chelated Bodipys10.1039/D3SC00854A ↗
54. Synthesis of BF2 chelates of tetraarylazadipyrromethenes and evidence for their photodynamic therapeutic behaviour10.1039/B204317C ↗
55. Bioapplications of small molecule Aza-BODIPY: from rational structural design to in vivo investigations10.1039/D0CS00234H ↗
56. Structural modification strategies for the rational design of red/NIR region BODIPYs10.1039/C4CS00030G ↗
57. Evolution of BODIPY/aza-BODIPY dyes for organic photoredox/energy transfer catalysis10.1016/j.ccr.2022.214698 ↗
58. Near-infrared absorbing (> 700 nm) aza-BODIPYs by freezing the rotation of the aryl groups10.1016/j.cclet.2021.06.083 ↗
59. Basic structural modifications for improving the practical properties of BODIPY10.1016/j.ccr.2022.214684 ↗
60. Boosting non-radiative decay to do useful work: development of a multi-modality theranostic system from an AIEgen10.1002/anie.201900366 ↗
61. The detection sensitivity of commonly used singlet oxygen probes in aqueous environments10.1016/j.jphotobiol.2020.111787 ↗
62. Targeted singlet oxygen delivery: a bioorthogonal metabolic shunt linking hypoxia to fast singlet oxygen release
63. Synthesis and triplet sensitization of bis(arylselanyl)BOPHYs; potential application in triplet-triplet annihilation upconversion10.1039/D1NJ00721A ↗
64. NIR light-driving barrier-free group rotation in nanoparticles with an 88.3% photothermal conversion efficiency for photothermal therapy10.1002/adma.201907855 ↗
65. A gas/phototheranostic nanocomposite integrates NIR-II-peak absorbing aza-BODIPY with thermal-sensitive nitric oxide donor for atraumatic osteosarcoma therapy
66. Choline phosphate lipid-hitchhiked near-infrared BODIPY nanoparticles for enhanced phototheranostics10.1039/D3TB00175J ↗
67. Aza-BODIPY-based nanomedicines in cancer phototheranostics10.1021/acsami.0c05021 ↗
68. A practical perspective on how to develop, implement, execute, and reproduce high-resolution respirometry experiments: the physiologist's guide to an Oroboros O2k10.1096/fj.202301644RR ↗
69. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy10.1002/jcp.25349 ↗